Clinical utility and implementation of polygenic risk scores for predicting cardiovascular disease

Scientific basis of polygenic risk scores (PRS) and evidence on their role in cardiovascular diseases (CVD) risk prediction for disease prevention; opportunities and challenges for implementation, evidence gaps, a potential roadmap to routine clinical care, clinical scenarios where PRS may hold most value, and organisational frameworks for responsible PRS testing